Company page

Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc. is a publicly traded company listed under the ticker SNDX on the American market. With a market capitalization of approximately $1.68 billion, Syndax focuses on developing innovative therapies for cancer and other serious diseases. The company is committed to advancing its pipeline of drug candidates to improve patient outcomes.